Evidence map›Paper›PMID 35366058›Full record

ArticleAmerican journal of medical genetics. Part A2022

Germline mosaicism of a missense variant in KCNC2 in a multiplex family with autism and epilepsy characterized by long-read sequencing.

Elvisa Mehinovic, Teddi Gray, Meghan Campbell, Jenny Ekholm, Aaron Wenger, William Rowell, Ari Grudo, Jane Grimwood, Jonas Korlach, Christina Gurnett and 2 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in American journal of medical genetics. Part A, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Developing a genetic return of results service core.Journal of clinical and translational science · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Elvisa MehinovicDepartment of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA.
Teddi GrayDepartment of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
Meghan CampbellDepartment of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
Jenny EkholmPacific Biosciences, Menlo Park, California, USA.
Aaron WengerPacific Biosciences, Menlo Park, California, USA.
William RowellPacific Biosciences, Menlo Park, California, USA.ORCID 0000-0002-7422-1194
Ari GrudoPacific Biosciences, Menlo Park, California, USA.
Jane GrimwoodHudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.
Jonas KorlachPacific Biosciences, Menlo Park, California, USA.
Christina GurnettDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
John N ConstantinoDepartment of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID 0000-0001-8888-4186
Tychele N TurnerDepartment of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID 0000-0001-8246-6477
Washington University in St. Louis · USPacific Biosciences (United States) · USHudsonAlpha Institute for Biotechnology · US

Funding

WUIDDRC Supplement-Supporting the health and well-being of children with intellectual and developmental disability during COVID-19 pandemicP50HD103525 · NICHD · WASHINGTON UNIVERSITY · PI JOSEPH D DOUGHERTY, Natasha Marrus · 2020 to 2026
$15.5M
Nature and contribution of noncoding, regulatory mutations in neurodevelopmental disordersR00MH117165 · NIMH · WASHINGTON UNIVERSITY · PI TURNER, TYCHELE NAOMI · 2019 to 2021
$743k
NICHD NIH HHS P50 HD103525NIMH NIH HHS R00 MH117165
6 · The paper itself

Abstract

Currently, protein-coding de novo variants and large copy number variants have been identified as important for ~30% of individuals with autism. One approach to identify relevant variation in individuals who lack these types of events is by utilizing newer genomic technologies. In this study, highly accurate PacBio HiFi long-read sequencing was applied to a family with autism, epileptic encephalopathy, cognitive impairment, and mild dysmorphic features (two affected female siblings, unaffected parents, and one unaffected male sibling) with no known clinical variant. From our long-read sequencing data, a de novo missense variant in the KCNC2 gene (encodes Kv3.2) was identified in both affected children. This variant was phased to the paternal chromosome of origin and is likely a germline mosaic. In silico assessment revealed the variant was not in controls, highly conserved, and predicted damaging. This specific missense variant (Val473Ala) has been shown in both an ortholog and paralog of Kv3.2 to accelerate current decay, shift the voltage dependence of activation, and prevent the channel from entering a long-lasting open state. Seven additional missense variants have been identified in other individuals with neurodevelopmental disorders (p = 1.03 × 10

Indexed as

Autistic DisorderEpilepsyShaw Potassium ChannelsChildFemaleGerm CellsHumansMaleMosaicismMutation, MissenseKCNC2 protein, humanShaw Potassium Channelsautismchannelepilepsygeneticsgenomicslong-read sequencing

Identifiers

PMID35366058
PMCPMC9197999
OpenAlexW4226025503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.